"Pharma Breakthroughs in 2023: Weight Loss, Alzheimer's, and Gene Editing"

In 2023, the pharmaceutical industry achieved significant milestones, including the rise of weight loss drugs as a lucrative market, the approval of the first drug to slow the progression of Alzheimer's disease, the rollout of the world's first vaccines against respiratory syncytial virus (RSV), and the approval of the first-ever gene-editing therapy for sickle cell disease. However, the demand for Covid vaccines and treatments declined, causing a financial burden on the industry. Additionally, the controversial Medicare drug price negotiations began, aiming to reduce prescription drug costs but facing opposition from pharmaceutical companies.